Around 4,200 children and young people are diagnosed with cancer every year in the UK. Thanks to research, more than 8 in 10 of those diagnosed today will survive for at least 10 years. But survival for some children’s cancers hasn’t improved much since the 1970s. And many of those who do survive experience long-term side effects from their treatment.
We’re determined to tackle the challenges holding back progress and ensure more children and young people survive cancer with a good quality of life. Research is redefining our understanding of the disease, and is setting new standards of care. But we still face significant challenges. By breaking down barriers between disciplines and by combining expertise we hope to open up new avenues for collaborative research in cancer cell biology, cutting edge drug discovery and novel approaches to the detection, monitoring and treatment of CYP cancers.
Sessions include:
- Unlocking the potential for data to transform outcomes
- Scientific distinctions between paediatric and teenage and young adult cancers
- Developing children and young people-specific therapeutics
- Improving research through meaningful patient and public involvement
- What funding for children's and young people's cancer research looks like
Call for abstracts:
All attendees are invited to submit an abstract to present a poster at the conference.
- Deadline for abstract submissions is 6 September 2023
- Applicants will be notified of acceptance from 25 September 2023
- The presenting author of the abstract must register and pay the registration fee.
Poster viewing will take place throughout the conference. Submit your abstract here